Calithera Biosciences, Inc.
Ectonucleotidase inhibitors and methods of use thereof
Last updated:
Abstract:
The invention relates to novel heterocyclic compounds having CD73 inhibitory activity and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.
Status:
Grant
Type:
Utility
Filling date:
27 Sep 2019
Issue date:
16 Nov 2021